SMTL ID : 8he8.2 (2 other biounits)

Human ADP-ribosyltransferase 2 (PARP2) catalytic domain bound to a quinazoline-2,4(1H,3H)-dione inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 3.05 Å

Oligo State

monomer

Ligands

1 x GOL: GLYCEROL(Non-functional Binders)

GOL.1: 7 residues within 4Å: Chain A: S.98, I.101, Q.102, E.105, G.224, Y.225 Ligands: 1WI.2 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:S.98, A:Q.102, A:E.105

1 x 1WI: 1-[[4-fluoranyl-3-(3-oxidanylidene-4-pentan-3-yl-piperazin-1-yl)carbonyl-phenyl]methyl]quinazoline-2,4-dione(Non-covalent)

1WI.2: 19 residues within 4Å: Chain A: E.105, D.109, W.197, H.198, G.199, N.204, L.213, R.214, Y.225, G.230, I.231, Y.232, F.233, A.234, K.239, S.240, Y.243, E.328 Ligands: GOL.1 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:E.105, A:N.204, A:Y.225, A:Y.232, A:Y.232, A:A.234, A:Y.243, A:E.328 Hydrogen bonds: A:G.199, A:G.199, A:R.214, A:Y.232 pi-Stacking: A:Y.232, A:Y.243

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Zhou, J. et al., Discovery of Quinazoline-2,4(1 H ,3 H )-dione Derivatives Containing a Piperizinone Moiety as Potent PARP-1/2 Inhibitors─Design, Synthesis, In Vivo Antitumor Activity, and X-ray Crystal Structure Analysis. J.Med.Chem. (2023)

Release Date

2023-11-08

Peptides

Poly [ADP-ribose] polymerase 2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Poly [ADP-ribose] polymerase 2

Related Entries With Identical Sequence